What drove GERN's EPS growth in Q3 2024?

Geron's EPS growth in Q3 2024 was driven by the launch of its flagship product, Rytelo, and the overall trajectory of the company's financial performance.

1. **Product Launch Metrics**: The promising initial launch metrics for Rytelo indicate a positive market reception, which is likely contributing to the company's revenue and, subsequently, its EPS growth.
2. **Financial Performance**: Geron's financial performance remains a focus for investors, with earnings per share (EPS) estimates for FY1 2024 at -$0.38, improving to an estimated -$0.20 for FY1 2025. This trajectory suggests that while the company is not yet profitable, analysts expect its financial position to strengthen over time.
3. **Analyst Forecasts**: Leerink Partners, an analyst firm, has issued forecasts for Geron's Q3 2024 earnings, anticipating an EPS of $0.09 per share for the quarter. This forecast, along with the consensus estimate for full-year earnings, suggests that the company's earnings are expected to be positive, albeit at a loss when considering the current fiscal year.

In conclusion, Geron's EPS growth in Q3 2024 is primarily driven by the successful launch of its flagship product, Rytelo, and the anticipated financial performance of the company, as indicated by analyst forecasts.